Mr. Chair, I will start off and then I may turn to a colleague with respect to what we're seeing in terms of the rates of positivity of imported cases.
Certainly we would look at the travellers coming in and the rates of positivity that we're seeing from those travellers, including where we may have associations with variants of concern, and that will impact the public health measures that we put in place and also what we learn and know about the timeline of—